- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02944695
Audit of Bronchoscopy Practice in Egypt: Adherence to Safety and Infection Control Guidelines
March 31, 2020 updated by: Aliae AR Mohamed Hussein, Assiut University
Adherence to Safety and Infection Control Guideline in Bronchoscopy Units
Both patient and staff safety are of major importance during the procedure of fibreoptic bronchoscopy.
Patient safety depends partly on adequate disinfection of instruments and accessories used as well as careful monitoring during the procedure.
Study Overview
Detailed Description
Adequate facilities, manpower and training are also essential.
Staff safety depends partly on adequate procedures to minimise any risks of sensitisation to agents such as glutaraldehyde.
An audit well be carried out of bronchoscopy procedures in hospitals in the Egypt and the findings well be compared with published guidelines on good practice and clinical consensus
Study Type
Observational
Enrollment (Anticipated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aliae AR Mohamed-Hussein
- Phone Number: +201222302352
- Email: aliaehussein@gmail.com
Study Locations
-
-
-
Assiut, Egypt, 71111
- Recruiting
- Pulmonology Departments
-
Contact:
- Aliae Mohamed-Hussein
- Phone Number: 882413711
- Email: massah_99@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Bronchoscopy Units personnel: Physicians- Nurses-workers
Description
Inclusion Criteria:
- Bronchoscopy Units personnel
Exclusion Criteria:
- N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Assessment of adherence to guidelines on disinfection procedures and patient monitoring
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
self- administered questionnaire
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Aliae Mohamed-Hussein, MD, Professor of Pulmonology- Faculty of Medicine-Assiut University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Anticipated)
July 1, 2020
Study Completion (Anticipated)
August 1, 2020
Study Registration Dates
First Submitted
October 22, 2016
First Submitted That Met QC Criteria
October 24, 2016
First Posted (Estimate)
October 26, 2016
Study Record Updates
Last Update Posted (Actual)
April 2, 2020
Last Update Submitted That Met QC Criteria
March 31, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AssiutU1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infection Control
-
Erasmus Medical CenterAmbu A/S; Maag Lever Darm StichtingCompletedEsophagogastroduodenoscopy | Gastroscopy | Equipment Design | Equipment Contamination / Prevention & Control | Cross Infection / Prevention & Control | Disposable Equipment | Infection Control / MethodsNorway, Netherlands
-
Peking Union Medical College HospitalTsinghua UniversityRecruitingInfection ControlChina
-
University of Maryland, BaltimoreCompletedInfection ControlUnited States
-
Madinah Saudi Board Community MedicineMadinah directorate - Ministry of HealthUnknownInfection Control Training
-
Ignacio Zaragoza GarcíaHospital Universitario 12 de OctubreCompletedInfection Control | Preventive MeasuresSpain
-
Malmö UniversityCompletedAntibiotic Prophylaxis | Infection ControlSweden
-
Cairo UniversityUnknown
-
County Durham and Darlington NHS Foundation TrustUnknownCross Infection | Infection ControlUnited Kingdom
-
Duke UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedSurgical Site Infection | Infection ControlUnited States
Clinical Trials on audit
-
Aga Khan UniversityBill and Melinda Gates FoundationEnrolling by invitationMaternal Death | Stillbirth | Neonatal DeathPakistan
-
Holdsworth House Medical PracticeGilead SciencesCompleted
-
Andalusian School of Public HealthHospital de Alta Resolucion de Loja. Agencia Sanitaria Hospital de PonienteNot yet recruiting
-
Assiut UniversityCompleted
-
Laval UniversityInstitut national en santé et services sociaux; Trauma Association of Canada; Health Standards Organisation and other collaboratorsNot yet recruiting
-
University of ManitobaManitoba Medical Service FoundationCompletedVitamin D Deficiency | Dementia | Viral InfectionCanada
-
CR-CSSS Champlain-Charles-Le MoyneWithdrawn
-
Fondazione C.N.R./Regione Toscana "G. Monasterio...CompletedRenal InsufficiencyItaly
-
Unity Health TorontoUnknownHIV/AIDS | Electronic Health Records | Quality of Health CareCanada
-
Karolinska InstitutetSeth Sukhlal Karnani Memorial Hospital; St Johns Medical College Hospital,... and other collaboratorsCompleted